DR. CARLOS E. LOPEZ, M.D.

Plain English
This study looked at how experiencing violence in the household during childhood affects people living with HIV in the U.S. Researchers found that nearly 19% of the 7,705 people with HIV reported such experiences. Those who had faced childhood household violence had lower adherence to HIV medication, more symptoms of HIV, and a poorer quality of life, primarily due to increased psychological distress and social stressors like stigma. Who this helps: This benefits patients with HIV, particularly those who experienced violence as children, by highlighting the need for mental health support.

Plain English
This study looked at how a new method of analysis helps us understand how joints move during different activities, specifically using advanced 4DCT scans of the wrist. The researchers found that wrist position has a clear effect on the space between bones in the wrist joint, particularly noting that when the wrist pronates (turns inward), the bones get closer together in certain areas. This is important because it helps us better understand joint mechanics, which can improve assessments and treatments for joint injuries. Who this helps: This benefits patients with wrist injuries and the doctors treating them.

Plain English
This study looked at how distractions, or mind-wandering, affect our ability to remember visual images. Researchers found that when people let their minds wander while looking at images, they were less likely to remember them accurately. Specifically, high-quality images were recognized better than low-quality ones, but distractions hurt recall for all images. This research matters because it shows that paying attention when learning can significantly improve memory, especially when the images are more memorable. Who this helps: This helps patients, especially those with memory concerns, by highlighting the importance of focus when learning new information.

Plain English
This study examined the effects of a liver condition called metabolic dysfunction associated steatotic liver disease (MASLD) on pregnancy outcomes. Researchers looked at 117 pregnant women with MASLD and found that, despite having more health issues like diabetes and obesity, there were no significant differences in pregnancy complications such as premature birth or low birth weight compared to 168 control women without liver disease. This means that MASLD and its severity do not directly impact maternal and fetal health, suggesting that other health factors related to metabolic syndrome are more influential. Who this helps: This information is valuable for patients with MASLD and their doctors, helping them understand that other health conditions may pose a greater risk during pregnancy.

Plain English
This study looked at the link between certain clinical factors in patients with sepsis and the development of new-onset atrial fibrillation (AF) in intensive care units in Medellín, Colombia. Out of 1,356 patients studied, 12.6% developed AF, and those who did had a higher risk of dying in the ICU (49% compared to 34%) and during their hospital stay (55% versus 37%). Understanding these risk factors is crucial because it can help doctors identify patients at greater risk and potentially improve their treatment. Who this helps: This benefits patients with sepsis and their doctors.

Plain English
This study looked at the risk of serious heart-related problems, known as major adverse cardiovascular events (MACE), in women who experienced heavy bleeding after giving birth. Out of more than 2,000 women studied, about 2% had MACE, with the most common issue being pulmonary oedema (fluid in the lungs). Women who had preeclampsia or heart disease were more likely to experience these events, and having a higher hemoglobin level before delivery seemed to lower the risk. Who this helps: This research benefits new mothers and their doctors by highlighting the need for close monitoring of women at risk after childbirth.

Plain English
This study looked at the effectiveness of a drug called larotrectinib in patients in Spain with certain types of solid tumors that have specific genetic changes known as TRK fusions. Out of 20 patients treated, 60% saw their tumors shrink, with a median duration of response lasting about 24.5 months, and 75% of those responding still had good results after one year. This matters because it shows that larotrectinib can work well for a variety of solid tumors with these genetic changes, helping to extend patients' lives. Who this helps: This helps patients with solid tumors that have TRK fusions and their doctors.

Plain English
This study is looking at a trial involving two types of advanced prosthetic hands for adults who have lost part of their arm. The researchers plan to include 36 participants and will compare how well each prosthetic performs in everyday activities and how satisfied users are with them. This research is important because it aims to enhance the functionality and user experience of prosthetic hands, which can significantly improve the quality of life for users. Who this helps: This helps patients who have lost their upper limbs.

Plain English
This research paper looked at the connection between substance use disorder (SUD) and intellectual and developmental disabilities (IDD). It found that while adults with IDD are generally less likely to use substances, those who do face a higher risk for SUD, with about 42-54% also having other mental health issues. Improving treatment by training healthcare providers to understand both IDD and SUD could lead to better health outcomes. Who this helps: This benefits patients with intellectual and developmental disabilities and the healthcare professionals who treat them.

Plain English
This study tested a tool called the Texas HCC Consortium Risk Index (THCC-RI) to see how well it can predict the risk of liver cancer (HCC) in patients with cirrhosis. Researchers followed 1,560 patients over about 2.5 years and found that 114 developed HCC. The tool effectively identified patients at high risk, showing that those in the highest risk group were 3.5 times more likely to develop liver cancer compared to those at medium risk, which is important for guiding early detection and treatment. Who this helps: This benefits patients with cirrhosis by helping doctors identify those at higher risk for liver cancer more accurately.

Plain English
This study looked at treatment options for early-onset mucinous adenocarcinoma of the colon in younger patients aged 20 to 50. Researchers analyzed data from over 2,500 patients between 2000 and 2020 and found that systemic therapy improved survival rates significantly for patients with stage III cancer, extending their cancer-specific survival by about 3.9 months and overall survival by about 5.2 months. The findings highlight the importance of aggressive treatment strategies, suggesting that even this type of cancer, which typically resists traditional therapies, can benefit from systemic therapy to improve outcomes. Who this helps: Patients diagnosed with early-onset mucinous adenocarcinoma of the colon.

Plain English
This study looked at how effective a new treatment called faricimab is for various eye diseases in patients from Latin America. It included 757 eyes from 732 patients, and the results showed that after several injections, patients with neovascular age-related macular degeneration gained an average of 9.1 letters in vision, while those with diabetic macular edema saw even greater improvements, gaining 12 letters on average. This matters because these improvements can lead to better quality of life for patients suffering from serious vision problems. Who this helps: Patients with retinal diseases like age-related macular degeneration and diabetic macular edema.

Plain English
This study looked at different blood tests to see how well they can detect liver cancer (HCC) in patients with liver damage (cirrhosis). Researchers compared a fixed blood test, GALAD, with four newer tests that track changes in blood markers over time. They found that while the fixed GALAD test identified 71.4% of cancer cases in the six months before diagnosis, it also had a higher false positive rate of 25.4%, meaning it indicated cancer when there wasn't any more often than the other tests, which had lower sensitivity but also fewer false alarms. Who this helps: This research benefits patients with cirrhosis by providing options for more accurate monitoring for liver cancer.

Plain English
This study looked at how health workers at an HIV clinic in the Southeastern U.S. experienced the introduction of a new long-acting injectable HIV treatment. They found that while workers were excited and aware of the new therapy called CAB/RPV, there were challenges such as communication gaps and pressure on staff, which could affect patient access to the treatment. Understanding these experiences is important because it can help improve the integration of new therapies in clinics, ensuring that patients receive the best care possible. Who this helps: This helps patients with HIV and the healthcare workers caring for them.

Plain English
This study looked at two methods for collecting initial blood samples: a commercial method and an open method. The research found that switching to the open method didn't affect the quality of blood cultures or patient treatment times, but it did lower laboratory costs by an unspecified amount. This is important because it means hospitals can save money without compromising patient care. Who this helps: This benefits hospitals and healthcare providers by reducing costs while maintaining patient care quality.

Plain English
This study developed a new testing method to measure gentamicin levels in pig blood and feces. The researchers created a reliable process that can accurately detect different forms of gentamicin, showing good results with a precision rate of up to 87% across various tests. This matters because it provides a better way for veterinarians to monitor the effectiveness of gentamicin treatment in pigs, ensuring the right dosage is given. Who this helps: Veterinarians treating infections in pigs.

Plain English
This study looked at how a special eye drop made from propylene glycol and hydroxypropyl guar could help people aged 18-50 with evaporative dry eye. Over three months, the treatment led to a significant decrease in eye discomfort and corneal staining, and it improved tear stability, with the average symptom score dropping from 43.1 to 25.2. Importantly, there were no reported side effects, showing that the treatment is both safe and effective. Who this helps: This benefits patients suffering from evaporative dry eye.

Plain English
This study looked into a new treatment approach using engineered regulatory T cells (EngTregs) to tackle IPEX and other autoimmune diseases caused by issues with the FOXP3 gene. The researchers developed EngTregs that effectively suppress harmful immune responses and found they could safely work in lab models without causing unwanted effects. This is important because it offers a potential new therapy for patients suffering from severe autoimmune disorders like IPEX, which currently have limited treatment options. Who this helps: This helps patients with IPEX and similar autoimmune conditions.

Plain English
This study looked at whether Ecuador, Colombia, and Peru stopped selling medicines that had been withdrawn globally for safety or effectiveness reasons between 2014 and 2025. It found that out of 53 medicines pulled from the market internationally, 17% were still available in Ecuador, while Colombia and Peru each had about 8% still being sold, despite many of these drugs being linked to serious health risks. This matters because it highlights a significant gap in safety regulations, which could put patients at risk of harmful side effects from these withdrawn medicines. Who this helps: Patients who rely on safe and effective medications.

Plain English
This study looked at how patients with knee osteoarthritis, their caregivers, and healthcare professionals view and experience weight loss, exercise, and education as ways to manage the condition. The review analyzed 75 studies involving over 1,300 patients and showed that positive beliefs about exercise and weight loss helped patients engage in these activities, while negative views and skepticism from doctors often discouraged them. This matters because a focus on positive experiences and tailored support can lead to better health outcomes for those with knee osteoarthritis. Who this helps: This helps patients with knee osteoarthritis and their caregivers by promoting effective self-management strategies.

Plain English
This study looked at how well immune checkpoint inhibitors (ICIs) work for patients with certain advanced gastrointestinal cancers that have high microsatellite instability (MSI-H) or mismatch repair deficiency (dMMR). The researchers followed 122 patients and found that those treated with ICIs had a median overall survival of 53.2 months and a median progression-free survival of 46 months. Most patients responded well to the treatment, with 77.7% experiencing a positive response and 91.1% having disease control, showing that ICIs are beneficial in real-world settings. Who this helps: This benefits patients with advanced MSI-H/dMMR gastrointestinal tumors and their doctors in making treatment decisions.